Comprehensive Observations of Co-occurrence of MPN Driver Mutations: JAK2, CALR, and MPL

被引：0

作者：

Ollila, P. ^{[1
]}

Artymiuk, C. ^{[1
]}

Bessonen, K. ^{[1
]}

Boerger, A. ^{[1
]}

Dina, M. ^{[1
]}

Mai, M. ^{[1
]}

Shi, M. ^{[1
]}

Wang, R. ^{[1
]}

Yuan, J. ^{[1
]}

Zhang, X. ^{[1
]}

Viswanatha, D. ^{[1
]}

He, R. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN USA

来源：

JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

H014

引用

页码：S34 / S34

页数：1

共 50 条

[41] Clinical outcomes of patients with JAK2, CALR and MPL positive myeloproliferative neoplasms
Komic, H.
Islamagic, E.
Kurtovic, S.
Burekovic, A.
Uzunovic, A.
Kurtovic-Kozaric, A.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1841 - 1842
[42] Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) andSF3B1
Ok, Chi Young
Trowell, Kevin T.
Parker, Kyle G.
Moser, Karen
Weinberg, Olga K.
Rogers, Heesun J.
Reichard, Kaaren K.
George, Tracy, I
Hsi, Eric D.
Bueso-Ramos, Carlos E.
Tam, Wayne
Orazi, Attilio
Bagg, Adam
Arber, Daniel A.
Hasserjian, Robert P.
Wang, Sa A.
MODERN PATHOLOGY, 2021, 34 (01) : 20 - 31
[43] Determination of Driver Mutations in JAK2, MPL, and Calreticulin in Coronary Patients with Suspected Essential Thrombocythemia
Gasser, Klaus
Muendlein, Axel
Kinz, Elena
Leiherer, Andreas
Steurer, Michael
Fraunberger, Peter
Drexel, Heinz
Lang, Alois
BLOOD, 2014, 124 (21)
[44] FREQUENCY OF CONCURRENT BCR-ABL1, JAK2, CALR AND MPL MUTATIONS IN A COHORT OF 5,545 CASES WITH SUSPECTED MPN BY A DEEP SEQUENCING APPROACH
Jeromin, S.
Meggendorfer, M.
Fasan, A.
Haferlach, C.
Kern, W.
Haferlach, T.
HAEMATOLOGICA, 2017, 102 : 538 - 538
[45] Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR
Wang, Zhanlong
Tian, Xin
Ma, Jinyu
Zhang, Yuhui
Ta, Wenru
Duan, Yifan
Li, Fengli
Zhang, Hong
Chen, Long
Yang, Shaobin
Liu, Enbin
Lin, Yani
Yuan, Weiping
Ru, Kun
Bai, Jie
CANCER MEDICINE, 2024, 13 (07):
[46] Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
Nangalia, J.
Massie, C. E.
Baxter, E. J.
Nice, F. L.
Gundem, G.
Wedge, D. C.
Avezov, E.
Li, J.
Kollmann, K.
Kent, D. G.
Aziz, A.
Godfrey, A. L.
Hinton, J.
Martincorena, I.
Van Loo, P.
Jones, A. V.
Guglielmelli, P.
Tarpey, P.
Harding, H. P.
Fitzpatrick, J. D.
Goudie, C. T.
Ortmann, C. A.
Loughran, S. J.
Raine, K.
Jones, D. R.
Butler, A. P.
Teague, J. W.
O'Meara, S.
McLaren, S.
Bianchi, M.
Silber, Y.
Dimitropoulou, D.
Bloxham, D.
Mudie, L.
Maddison, M.
Robinson, B.
Keohane, C.
Maclean, C.
Hill, K.
Orchard, K.
Tauro, S.
Du, M-Q
Greaves, M.
Bowen, D.
Huntly, B. J. P.
Harrison, C. N.
Cross, N. C. P.
Ron, D.
Vannucchi, A. M.
Papaemmanuil, E.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25): : 2391 - 2405
[47] Co-occurrence of Driver Mutations in Myeloid Neoplasm
Richardson, Aida
White, Thomas
Karner, Kristin
Patel, Jay
MODERN PATHOLOGY, 2019, 32
[48] Co-occurrence of Driver Mutations in Myeloid Neoplasm
Richardson, Aida
White, Thomas
Karner, Kristin
Patel, Jay
LABORATORY INVESTIGATION, 2019, 99
[49] Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia
Usseglio, Fabrice
Beaufils, Nathalie
Calleja, Anne
Raynaud, Sophie
Gabert, Jean
JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (01): : 92 - 98
[50] Calr Vs. JAK2 Vs. MPL Mutations in the Progression of Philadelphia-Negative Myeloproliferative Neoplasms
Bai, Jie
Sheng, Mengyao
Xing, Wen
Bai, Jiaojiao
Li, Rong
Shi, Jun
Zhang, Lei
Yuan, Weiping
Yang, Feng-Chun
Zhou, Yuan
BLOOD, 2017, 130

← 1 2 3 4 5 →